abstract |
The present invention is directed to quinazolinone compounds that are antagonists of T-type calcium channels and are useful for the treatment or prevention of disorders and diseases involving T-type calcium channels. The present invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases involving T-type calcium channels. |